Pharmacovigilance – News and Features
News
This Alloy Is Kinky
A metal alloy composed of niobium, tantalum, titanium and hafnium has shocked materials scientists with its impressive strength and toughness – its secret? A rare kink band defect.
News
Increasing T-Cell Survival To Improve Cancer Immunotherapy
T-cell exhaustion can prevent optimal responses to immunotherapy, but a new cytokine "cocktail" may help increase T-cell survival.
News
Rice Bran Nanoparticles Show Promise as Anti-Cancer Agent
Plant-derived nanoparticles, including those from rice bran, could be used as alternatives to traditional cancer treatments.
News
Immunotherapy Developed To Localize Cancer-Killing Molecules
A new immunotherapy has been developed that localizes cytokines to tumors for weeks while preserving their activity.
News
Fibrin Immunotherapy’s Potential for Treating Traumatic Brain Injury
Traumatic brain injuries come with an amplified risk for developing dementia, but a new therapeutic target and a potential immunotherapy have been identified.
Article
Extended Blood Typing Needed for Improving Transfusion Safety
Explore how high-throughput DNA-based genotyping can offer a cost-effective way to screen extended blood types.
News
Improving Metabolic Health Before Vaccination Helps Protect Against Influenza
Scientists at St. Jude Children’s Research Hospital have shown that improving metabolic health in obese mice before vaccination, but not after, protects against influenza virus.
News
Promising Treatment Approach for Aggressive Leukemia Identified
Blocking oxygen-sensing enzymes in cancer cells can significantly halt acute myeloid leukemia in patient samples without affecting the production of normal blood cells.
News
Cell Therapy Treatment Effectively Treats Immune-Compromised Children
In a first-of-its-kind clinical trial, researchers found that intravenous therapies made from virus-specific T-cells (VST) can effectively treat immunocompromised pediatric patients, far surpassing the current standard of care.
Advertisement